Competition & Peer Data API & CSV Delivery Connect to AI Assistant via MCP

Citius Oncology Inc's Competitiveness

A competitive positioning analysis and financial ratio benchmarking of Citius Oncology Inc (TENKU) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.

Peer Data As of Q3 2026
Competitors Tracked
-
Publicly traded peers
Peer Group Market Share
100.00 %
Share of combined sales, Q3 2026
Revenue Growth Y/Y
-
Q3 2026
Net Margin
-597.40 %
Q3 2026

Key Findings: Citius Oncology Inc vs Its Competitors

  • Peer revenue share: Citius Oncology Inc accounted for 100.0% of combined revenue among its tracked peer group.

Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).

TENKU Sales vs. its Competitors, Q3 2026

Citius Oncology Inc generated 100.00 % of the combined sales of its peer group.

API endpoints for this dataset
https://api.csimarket.com/api/v1/companies/TENKU/competitors
https://api.csimarket.com/api/v1/companies/TENKU/relationships
https://api.csimarket.com/api/v1/companies/TENKU/similar
Programmatic access for models, analytics, and integration workflows.

Market Share of the Peer Group, Q3 2026

100%market share
  • Citius Oncology Inc100.0%
  • Competitors combined0.0%

Share of combined quarterly revenue of Citius Oncology Inc and its 0 tracked competitors.

See Citius Oncology Inc's full market share breakdown »

TENKU Stock Performance relative to its Competitors

TENKU Competitors (weighted) Percent change over the selected range
Get the full CSIMarket dataset: Subscribe API License